How much time will this take for me and my staff?

The research check takes very little of your time: one short call and a simple count your team runs in your EMR. Once a study starts, the investigator oversees it and a trained coordinator handles day-to-day visits and data. The workload depends on the protocol, and we'll walk you through a realistic estimate for each study before you commit.

What does it cost to join?

Nothing. There is no cost to join and no cost for the practice research check, and you are under no obligation. Any arrangement with Amavita Research is set out in a written agreement at fair-market value before you sign anything.

Is there a long-term commitment?

No. There is no exclusivity, and you can step away with notice under the written agreement. We don't buy practices; your practice and your patients stay yours.

How is my patients' data protected?

For the research check, your team runs the counts inside your own EMR and only de-identified totals are shared with us. No patient data leaves your practice, and your staff make first contact with any patient. Once a study starts, identifiable information is used only as the study's IRB-approved process and HIPAA allow, usually after the patient signs consent and authorization.

Do my patients stay my patients?

Yes. You remain their doctor. Participation is voluntary, patients can withdraw at any time, and their routine care stays with you.

Which therapeutic areas?

We start where our experience runs deepest: cardiovascular and cardiometabolic conditions such as hypertension and heart failure. We'll look at other areas common in primary care, internal medicine, pulmonology, endocrinology and nephrology case by case, based on what sponsors are running and what your panel supports.

How fast will the first study arrive?

Plan on several months from our first conversation to your first study patient. It depends on which sponsor studies are open, whether your patients match, and the sponsor's own site-selection and start-up process, so we can't promise a date. After the research check, we'll give you a straight answer on what is realistic.

Do I need research experience?

No. Many first-time investigators start with solid clinical experience and strong training. We provide GCP and protocol training for you and your staff. The sponsor makes the final decision on site selection.

For independent practices

Your practice could be a clinical trial site. We handle the hard parts.

Q: Do you work with practices outside South Florida?

Yes. Amavita Research works with independent practices across Florida and beyond, with remote study support plus on-site coordinator support where needed.

Amavita Research helps independent practices become research sites for industry-sponsored clinical trials, with your own physician as investigator. We provide site management and support: study sourcing, contracts, IRB, training and quality. Your patients stay your patients, and their study visits happen at your practice.

There’s no cost to join, and your team is paid at fair-market value for the research work it does. We don’t buy practices, so your practice and your patients stay yours.

Get a free practice research check Or book a 20-minute call with Julio →

GCSA-certified Miami clinical trial site · ICH-GCP E6 (R3) · 19 pharma and device sponsors across active and completed trials

The patients you already see may qualify for studies sponsors are running now.

Drug and device companies need doctors and patients to run clinical trials. Many of these studies are in conditions you treat every day, such as high blood pressure, heart failure and other chronic diseases.

Sponsors tend to go back to research sites they already know. That means many independent practices with large, loyal patient panels are never asked to take part.

Adding research to your practice can mean:

A new source of practice revenue, earned through research work your team performs, separate from your fee-for-service billing.
One more option for your patients: a study close to home, with their own doctor involved.
Early, hands-on experience with therapies still in development.
New skills and a growth path for your staff.

Trials are not right for every patient, and an investigational treatment may not help. Taking part is always voluntary and starts with informed consent.

You see patients. We run the research machinery.

Study sourcing and sponsor relationships

We find studies that fit your patients and specialty, and we make the introduction to the sponsor.

Contracts and budgets

We help negotiate the clinical trial agreement and budget so that every line pays fairly for the work.

IRB and regulatory work

Submissions, essential documents, investigator paperwork and amendments, prepared and tracked.

Coordinator training and GCP

We train your staff on ICH-GCP E6 (R3), the protocol and the study systems.

Quality and monitoring readiness

Source documents, checklists and audit-ready files, so monitor visits go smoothly.

Billing separation

We help set up a coverage analysis so that study-paid items are never billed to patients or their insurance, and routine care is billed correctly.

We work with independent practices across Florida and beyond, with remote study support plus on-site coordinator support where needed.

What we ask of you

A physician investigator's time — A licensed physician in your practice who agrees to oversee each study and set aside regular time for it. That role carries real responsibilities, and we help you meet them.
An exam room — Space for study visits, secure storage for study supplies, and a place where a monitor can review records.
A staff point of contact — One team member who coordinates with us and can be trained as a study coordinator.
Openness to training — GCP and protocol training for your investigator and staff, which we provide.

Three steps, and you stay in control at every one

Step 1 — Free research check
Your own team runs simple aggregate counts inside your EMR, with our guidance, for example "adults with high blood pressure seen in the last 12 months." Only de-identified totals are shared with us. No patient data leaves your practice: no names, no charts and no PHI. You get a short summary of the types of studies your panel could support.
Step 2 — Matching a study
When a sponsor study fits, your own team reviews records under the study's IRB-approved process, and your staff make first contact with any patient. You decide which patients to talk to. Each patient decides whether to take part, after informed consent.
Step 3 — Your practice becomes a research site
Your practice is the research site and your physician is the investigator. We take you through the contract, budget, IRB approval, training and site initiation, then stay with you through monitoring visits, enrollment and closeout.

An honest timeline: plan on several months from our first conversation to your first study patient. It depends on which studies are open, whether your patients match, and each sponsor’s site-selection and start-up process, so we don’t promise dates.

Choose how involved you want to be

Start where you’re comfortable. Many practices begin with the first path and move up over time.

Free research check

Your team runs simple de-identified counts inside your EMR, and we show you which kinds of studies your panel could support.

Time commitment: Light. A short call and a simple count in your EMR.
Experience needed: None.

Partner site with our coordinator

Your practice is the research site and your physician is the investigator, with an Amavita Research coordinator supporting the day-to-day study work.

Time commitment: Moderate. Investigator oversight plus space for study visits.
Experience needed: Some.

Full investigator site

Your own trained team runs studies at your practice, with Amavita Research providing site management and support: sourcing, contracts, regulatory work and quality.

Time commitment: Higher. A trained in-house coordinator and regular investigator time.
Experience needed: Some.

We never pay for referrals or pre-screening. Research work is paid at fixed, fair-market-value rates set in a written agreement, and the sponsor makes the final decision on site selection.

How sites get paid, explained simply

Sponsors pay research sites for work performed. The terms are set in a written clinical trial agreement and a budget negotiated before the study starts. Payments are at fair-market value for that work. They are never for referrals, and they are never tied to which treatment a patient receives.

A typical site budget includes:

Startup fee: pays for getting the study ready (regulatory documents, training, systems setup).
Per-visit payments: a set amount for each protocol visit your team completes and documents.
Per-procedure payments: for protocol-required procedures, such as ECGs, labs or questionnaires, that are not part of routine care.
Screen-fail payments: for screening work done when a consented person turns out not to be eligible.
Administrative fees: for items such as IRB fees, monitoring visits, record storage and closeout.

How pay works

Fixed, fair-market-value rates for the research work your team does, agreed in writing before a study starts.
Transparent budgets: you see every line before you sign.
No percentages of study budgets, and no pay per referral or per pre-screen.
No exclusivity. You can step away with notice.

Real budgets vary widely by sponsor, protocol and phase. We review every line with you before you sign.

Research income is not guaranteed. It depends on the studies available, on eligibility and on the work your team completes.

Built by people who run a real trial site

Florida-based, bilingual support — Our team is in Miami and works in English and Spanish, with remote study support and on-site coordinator support where needed.
Direct access to Julio — You work directly with our CEO, Julio G. Martinez-Clark, who has 20+ years of experience in clinical research operations across the Americas.
Cardiovascular depth — Our investigators include Dr. William W. O'Neill, MD, FACC, and Dr. Pedro Martinez-Clark, MD, FACC. Our affiliated cardiovascular ASC in Kendall, Advanced Cardiovascular of Miami, has 8 monitored observation beds with continuous ECG telemetry.
A path to device sponsors through bioaccess® — Julio is also CEO of our sister company bioaccess®, a CRO that runs first-in-human device and drug studies in Latin America. Device companies that start there often look for US sites next, and we can introduce partner practices when a protocol fits.
We operate a trial site ourselves — Amavita Research is a GCSA-certified (Feb 2025), ICH-GCP E6 (R3) cardiovascular clinical trial site in Miami and the research arm of amavita Heart and Vascular Health®, an independent Miami cardiovascular practice. Six studies are active now, with 19 pharma and device sponsors across active and completed trials, including Pfizer, Alnylam and Pharmacosmos.

Julio G. Martinez-Clark, CEO, Amavita Research · CEO, bioaccess®

Frequently asked questions

See what your practice could support

Start with a free research check. Your team runs the counts, only de-identified totals are shared, and there’s no obligation.

Get a free practice research check Book a 20-minute call →

julio@amavita.health · 786-703-5941

Amavita Research Services, LLC is a clinical trial site. It is not a CRO. Sponsors pay for research services at fair-market value under written agreements. We do not pay for patient referrals. Clinical trial participation is voluntary and requires IRB-approved informed consent.